1. Home
  2. PMAX vs GRCE Comparison

PMAX vs GRCE Comparison

Compare PMAX & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMAX
  • GRCE
  • Stock Information
  • Founded
  • PMAX 2019
  • GRCE 2002
  • Country
  • PMAX Hong Kong
  • GRCE United States
  • Employees
  • PMAX N/A
  • GRCE N/A
  • Industry
  • PMAX
  • GRCE
  • Sector
  • PMAX
  • GRCE
  • Exchange
  • PMAX Nasdaq
  • GRCE NYSE
  • Market Cap
  • PMAX 32.0M
  • GRCE 35.6M
  • IPO Year
  • PMAX 2024
  • GRCE N/A
  • Fundamental
  • Price
  • PMAX $0.45
  • GRCE $3.45
  • Analyst Decision
  • PMAX
  • GRCE
  • Analyst Count
  • PMAX 0
  • GRCE 0
  • Target Price
  • PMAX N/A
  • GRCE N/A
  • AVG Volume (30 Days)
  • PMAX 2.5M
  • GRCE 132.1K
  • Earning Date
  • PMAX 02-21-2025
  • GRCE 02-13-2025
  • Dividend Yield
  • PMAX N/A
  • GRCE N/A
  • EPS Growth
  • PMAX N/A
  • GRCE N/A
  • EPS
  • PMAX 0.04
  • GRCE N/A
  • Revenue
  • PMAX $5,970,263.00
  • GRCE N/A
  • Revenue This Year
  • PMAX N/A
  • GRCE N/A
  • Revenue Next Year
  • PMAX N/A
  • GRCE N/A
  • P/E Ratio
  • PMAX $10.47
  • GRCE N/A
  • Revenue Growth
  • PMAX 30.05
  • GRCE N/A
  • 52 Week Low
  • PMAX $0.34
  • GRCE $2.13
  • 52 Week High
  • PMAX $4.70
  • GRCE $4.97
  • Technical
  • Relative Strength Index (RSI)
  • PMAX N/A
  • GRCE N/A
  • Support Level
  • PMAX N/A
  • GRCE N/A
  • Resistance Level
  • PMAX N/A
  • GRCE N/A
  • Average True Range (ATR)
  • PMAX 0.00
  • GRCE 0.00
  • MACD
  • PMAX 0.00
  • GRCE 0.00
  • Stochastic Oscillator
  • PMAX 0.00
  • GRCE 0.00

About PMAX Powell Max Limited Class A Ordinary Shares

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.

About GRCE GRACE THERAPEUTICS INC

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

Share on Social Networks: